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Binding Structure
of Elastase Inhibitor Scyptolin A
peptolins is variable in length and composition and often
N blocked by hydrophobic acids [4].
The cyanopeptolins scyptolin A and B were detected
Ute Matern,1,3 Christian Schleberger,2,3
Stjepan Jelakovic,2 Ju¨rgen Weckesser,1
and Georg E. Schulz 2,*
1Institut fu¨r Biologie II in cultures of the terrestrial cyanobacterium Scytonema
hofmanni [8]. The N-terminal arm is N-butyroyl-Ala-Thr inMikrobiologie
Albert-Ludwigs-Universita¨t scyptolin A, whereas scyptolin B has a second N-butyroyl-
alanyl group esterified to the hydroxyl of Thr2 (FigureScha¨nzlestrasse 1
2Institut fu¨r Organische Chemie und Biochemie 1), resulting in the branched N-terminal arm (N-butyroyl-
Ala)2Thr [8]. Both compounds contain a 3-chloro-N-methyl-Albert-Ludwigs-Universita¨t
Albertstrasse 21 Tyr (cmTyr), the amide methylation of which facilitates
the formation of the preceding cis-peptide bond. TheD-79104 Freiburg im Breisgau
Germany two scyptolins were shown to inhibit elastase [8], which
characteristically degrades elastin forming the basis of
flexible connective tissues [9]. An imbalance between
such a protease and its natural inhibitors may lead toSummary
excessive proteolysis, giving rise to the development
of diseases such as pancreatitis, arthritis, emphysema,Natural bioactive compounds are of general interest
cystic fibrosis, or psoriasis [10]. Here we report the crys-to pharmaceutical research because they may be used
tal structure of an elastase in complex with its inhibitoras leads in drug development campaigns. Among
scyptolin A which reveals how the inhibitor uses its fourthem, scyptolin A and B from Scytonema hofmanni
N-terminal amino acid residues to bind specifically toPCC 7110 are known to inhibit porcine pancreatic elas-
the enzyme and its ring moiety to exclude water and,tase, which in turn resembles the attractive drug target
thus, hydrolysis. These data constitute a lead for theneutrophil elastase. The crystal structure of scyptolin
development of antielastase drugs.A as bound to pancreatic elastase was solved at 2.8 A˚
resolution. The inhibitor occupies the most prominent
subsites S1 through S4 of the elastase and prevents
Results and Discussion
a hydrolytic attack by covering the active center with
its rigid ring structure. The observed binding structure
Interaction of Scyptolin A with Elastase
may help to design potent elastase inhibitors.
Purified scyptolin A was added in excess to a solution of
porcine pancreatic elastase, and cocrystallization was
Introduction accomplished by the hanging drop vapor diffusion tech-
nique. The resulting space group, P622, is rare. The
Cyanobacteria produce numerous secondary metabolites lacking screw axis explains the small crystal dimension
[1, 2]. Early studies focused on the toxic peptide metabo- along the 6-fold axis. Various attempts to crystallize a
lites of freshwater species [3]. Meanwhile, nontoxic com- similar complex with scyptolin B failed, although A and
pounds such as cyanopeptolins have also become of B show the same binding behavior in solution. X-ray
general interest. Cyanopeptolins are produced by vari- diffraction data were collected to 2.8 A˚ resolution (Table
ous cyanobacteria species [4] and show remarkable bio- 1). An initial (Fo-Fc) electron density map showed the
activity [5]. For example, a strong protease inhibitory inhibitor binding conformation unambiguously (Figure
action was documented for A90720A from Microchaete 2). The electron density at the 3  contour level was
loktakensis, for several micropeptins from Microcystis continuous, excluding a covalent bond with the enzyme.
aeruginosa or M. viridis, for oscillapeptin from Oscilla- The two crystallographically independent elastase-
toria agardhii, and for nostopeptins and nostocyclin inhibitor complexes in the crystal were coupled by a
from Nostoc species [6]. Cyanopeptolins contain a 19- noncrystallographic symmetry relationship across a lo-
membered ring generated from six amino acid residues cal 2-fold axis. This improved the model appreciably but
by lactone formation between a side chain hydroxyl diminished all differences between the two complexes.
group of the first residue and the C-terminal carboxylate The resulting root-mean-square deviation of all atoms
(Figure 1). The lactonization classifies them as depsi- was only 0.025 A˚ for the peptides and 0.021 A˚ for the
peptides. Associated with the large ring, cyanopeptolins inhibitors. In the following, we therefore refrain from
contain a 6-membered ring formed by an Ahp residue, distinguishing between the two copies. The inhibitor
which is a glutamate--aldehyde bound as a hemiaminal molecules contact each other across the local 2-fold
to the amide nitrogen of the following amino acid [7]. axis that, however, does not seem to perturb their con-
The double ring is compressed by a cis-peptide bond formations. However, this contact excludes an equiva-
and rigidified by two strong internal hydrogen bonds, lent crystalline complex with scyptolin B because the
as sketched in Figure 1. The N-terminal arm of the cyano- additional Thr2-O substituent of scyptolin B would
clash with the other molecule.
As sketched in Figure 1 and detailed in Figure 3, scyp-*Correspondence: schulz@bio.chemie.uni-freiburg.de
3These authors contributed equally to this work. tolin A used its four N-terminal amino acid residues to
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hydrolysis did not occur, as the continuous (Fo-Fc) elec-
tron density of the 19-membered ring excludes a split
of the peptide bond. Further hydrogen bonds were made
between Ala1-O of the inhibitor and Arg226-N of elas-
tase and between Thr6-O of the inhibitor and Thr44-O.
Moreover, scyptolin A accommodates a conspicuous
water molecule hydrogen bonded to Thr2-O, Thr3-O,
and cmTyr7-O. This water has Gln200-N of the enzyme
as a fourth partner and is bound in an ideal tetrahedral
geometry. This water is likely to further rigidify the large
ring. The butyroyl group and the chlorine substituent
are in nonpolar environments. The shape and size of
scyptolin A allow a snug fit in the active center pocket
(Figure 2B).
Inhibition studies of elastase showed an IC50 value of
0.16 M for both scyptolins A and B [8]. Note that the
side chain of Thr2 points to the solvent (Figure 2B) so
that scyptolin B should fit elastase as well as scyptolin
Figure 1. Covalent Structures of the Cyanopeptolins Scyptolin A A. The IC50 values for trypsin were about 100-fold higherwith R  H and Scyptolin B with R  N-Butyroyl-Alanyl
[8], although the scyptolin A binding mode to elastase
All amino acid residues have the L configuration; the oligopeptide
can be transferred to the structurally related trypsinis numbered as usual. Ahp stands for 3-amino-6-hydroxy-2-piperi-
without causing serious clashes. However, two hydro-done. A cis-peptide bond is formed between Thr6 and cmTyr
gen bonds to the N-terminal arm of scyptolin A cannot(3-chloro-N-methyl-Tyr). The lactone cyclization classifies the mol-
ecule as a depsipeptide. The indicated elastase subsites S1 through be formed with trypsin, and Leu4 of the inhibitor cannot
S4 place the scissile bond between Leu and Ahp. bind favorably in the trypsin specificity pocket that is
built for Lys or Arg. These differences may explain why
scyptolin A is not an efficient trypsin inhibitor.bind at subsites S1 through S4 of elastase, forming main
chain hydrogen bonds like in an antiparallel  sheet. At
subsite S1, Leu4-O filled the oxanion hole interacting Comparison with Other Inhibitors
with the amides of residues 201, 202, and 203. However, The elastase-scyptolin A complex showed that subsites
S1 through S4 are most important, whereas subsites
S1, S2, etc. at the other side of the scissile bond cannot
Table 1. Data Collection, Phasing, and Refinement Statisticsa
be easily defined. The same difference was reported
Data Collection for several other elastase-inhibitor complexes [11–15].
Among them, binding studies with an elastase-inhibitingResolution range (A˚) 30–2.8 (2.86–2.80)
Number of unique reflections 16,453 (999) casein peptide [12, 13] revealed that only subsites S1
Multiplicity 8.3 (8.4) through S4 were occupied and that the substrate had
Completeness 99 (100) formed an ester with the enzyme (Figure 3). This struc-
Rsym-I (%) 13.3 (39) ture also contained a water molecule in a suitable loca-
I/I 13.6 (5.5) tion for ester hydrolysis [13], which is depicted in Figure
Molecular Replacementa 3. This “hydrolytic water” is at the same position as the
Ahp residue within the 19-membered ring of scyptolinRotation (Rf/) 6.52/4.43/4.30
Translation at best rotations (R factor) 0.41 A (Figure 3), demonstrating that the macrocycle of the
scyptolins occupies the crucial part of the active centerRefinement
pocket, thus preventing hydrolysis. Further elastase in-
Number of protein atoms 3,644 hibitor complex structures were reported for the Strep-
Number of inhibitor atoms 136
tomyces peptide derivative FR901277 [14] and for theNumber of water molecules 105
designed inhibitor FR136706 [15]. The latter two inhibi-Average B factor (A˚2) 24.5
tors also filled the active center pocket well, albeit withRcryst 0.209
Rfree (10% test set) 0.258 chemical structures that deviated appreciably from
Rmsd bond lengths/bond angles 0.007 A˚/1.35 scyptolin A, opening a different approach to elastase
Ramachandran plot favored/allowed (%)b 83/16 inhibition.
The space group was P622 with unit cell parameters a b 155.9 A˚ The binding structure of scyptolin A to elastase should
and c  91.0 A˚, two elastase molecules per asymmetric unit, and be compared with that of cyanopeptolin A90720A to
a solvent content of 61%. The data were collected at 100 K using the structurally related bovine pancreatic trypsin [16]. A
Cu K	 radiation. Numbers in parentheses refer to the last shells. All
superposition of the inhibitors showed nearly identicaldata were used without  cutoff.
conformations of the 19-membered rings, including thea The three best solutions of the rotation function of MOLREP [20]
Ahp residues and the two internal hydrogen bonds, al-are given. The first two were related to each other by a local 2-fold
axis representing the noncrystallographic symmetry of the two mol- though residues Leu4, Thr6, and cmTyr7 of the scyptol-
ecules in the asymmetric unit. ins are exchanged for Arg, Leu, and mTyr of A90720A,
b Residues His75 and Tyr178 were in the generously allowed respectively. The Leu to Arg exchange before the scis-
region [27].
sile bond of course reflects the specificity difference
Elastase-Scyptolin A Complex
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Figure 2. Stereo Views of Scyptolin A Binding to Porcine Pancreatic Elastase
(A) Ribbon plot of elastase with the initial (Fo-Fc) electron density map of scyptolin A at a contour level of 3 . The final model of scyptolin A
is drawn into the density. The side chains of the catalytic triad of elastase are given for reference (pink).
(B) Stereo view of scyptolin A bound to elastase represented by its molecular surface. The catalytic triad beneath the surface is shown; the
putative nucleophilic attack of the serine is indicated by a dashed red line. The inhibitor with its rigid cyclic peptide structure sits snugly in
the active center pocket.
between elastase and trypsin. The N-terminal arm of for the degradation and/or reorganization of elastic
fibers in vertebrate tissues, such as skin, blood ves-A90720A consists of a D-Leu that is N blocked by
(R )-glycerate-3-sulfate. In both instances, the 19-mem- sels, and lungs. Since scyptolin A inhibits elastase at
submicromolar concentrations [8], it constitutes a leadbered ring remained intact as no ester was formed with
the catalytic serine of the enzyme. In conclusion, the for the design of drugs counteracting elastase-related
diseases such as emphysema. A comparison with cya-two cyanopeptolins show closely related ring structures
and a similar inhibition geometry, although at different nopeptoline A90720A binding to trypsin [16] revealed
closely related conformations of the 19-memberedenzymes [16].
rings and similar binding interfaces. In contrast to
these two cyanopeptolins, synthetic inhibitors use aSignificance
broad range of binding modes [11].
Although little is known about the ecological impactSeveral cyanopeptolins are known to inhibit serine
proteases, some of which fulfill important functions of the cyanopeptolins, it has been proposed that some
metabolites of marine cyanobacteria act as feedingand thus constitute potential targets for pharmaceuti-
cal research. The serine protease elastase is required deterrents [17]. These cyanobacteria commonly pro-
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Figure 3. Stereo View of the Elastase Binding Structure of Scyptolin A Superimposed with that of the Elastase-Inhibiting Peptide Val-Glu-
Pro-Ile
Val-Glu-Pro-Ile is derived from -casein [13] and forms an ester bond to the catalytic Ser203 (green). The casein peptide structure [13] reveals
the four subsites S1 through S4 that bind the substrate, forming an antiparallel  sheet interface. It also contains a water molecule at a
position suitable for hydrolysis (green). The four N-terminal amino acid residues of scyptolin A occupy subsites S4 through S1 of elastase. The
internal water molecule stabilizing the ring structure of scyptolin A is shown.
in the B-factor refinement. Figures were produced with the programsduce a broad spectrum of peptide metabolites and
MOLSCRIPT [24], POVScript [25], and RASTER3D [26].grow in mixed assemblages with other organisms,
usually bacteria or diatoms [2]. The adaptive advan-
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